Announcements Trials
Browse Landscape

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 13Observational 2

Sponsor

Conditions

Neoplasms 276Breast Neoplasms 266Lung Neoplasms 127Prostatic Neoplasms 124Colorectal Neoplasms 105Carcinoma, Non-Small-Cell Lung 104Pancreatic Neoplasms 70Carcinoma, Hepatocellular 58Stomach Neoplasms 55Hematologic Neoplasms 52Urinary Bladder Neoplasms 50Multiple Myeloma 50Ovarian Neoplasms 49Brain Neoplasms 49Esophageal Neoplasms 46Leukemia, Myeloid, Acute 45Melanoma 44Head and Neck Neoplasms 42Colonic Neoplasms 41Disease 40Neoplasm Metastasis 39Liver Neoplasms 39Rectal Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 32Lymphoma 32Uterine Cervical Neoplasms 31Endometrial Neoplasms 30Thyroid Neoplasms 29Recurrence 29Leukemia, Lymphocytic, Chronic, B-Cell 29

Interventions

ziconotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Chronic Pain × 90 days × Clear all
NCT07499882 2026-03-30

Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy

Christian Hospital Northeast Northwest

Not yet recruiting
24 enrolled

Chronic Pain

NCT05674240 2026-03-27

Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain

Wake Forest University Health Sciences

Completed
30 enrolled

Cancer Pain, Neuralgia, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡